Pfizer/BioNTech and Moderna, the two biggest COVID vaccine makers for the United States, are both seeking emergency authorization from the FDA for bivalent vaccine boosters for children.
For the Moderna booster, children 12 to 17 would receive the same dose as older people, while children 6 to 11 would get a half dose from the same vial, the“If authorized by FDA, CDC anticipates a recommendation for bivalent COVID-19 vaccine as a booster for pediatric age groups in early to mid-October,” the CDC document said.
Moderna also tweeted that an application for children ages 6 months to under 6 years should be completed later this year. The bivalent boosters, which target both the original COVID strain and the BA.4 and BA.5 strains of Omicron, became available earlier this month for older people who have completed a primary vaccination series. Moderna’s bivalent booster is now given to people 18 and older and Pfizer’s is given to people 12 and older.
The newest booster became available to the public around Labor Day weekend, and about 4.4 million people have gotten it as of Sept. 21, according to the CDC.Pfizer: “Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age.”CDC: “UPDATED: CDC Fall Vaccination Operational Planning Guide.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
Read more »
Pfizer CEO tests positive for COVID for a second timeAlbert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster.
Read more »
Pfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsIf the FDA agrees, children would start getting a kid-sized dose of the new omicron-targeted formula.
Read more »
Pfizer Requests Clearance for Children’s Covid-19 BoosterPfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years, just as retooled shots for people 12 and older roll out.
Read more »
Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Read more »